ArticleTrials2022

A phase III randomized trial of weight loss to reduce cancer-related fatigue among overweight and obese breast cancer patients: MEDEA Study design.

Antonio Di Meglio et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.